Dominari Holdings Inc. is a holding company. The Company through its various subsidiaries, is engaged in financial services, investment advising and wealth management, asset management, investment banking, the acquisition of interests in high-growth industries, and biotechnology and pharmaceutical research and development. The Company is also developing a broad-spectrum antiviral platform, in which the lead compounds have activity in cell-based assays against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, Severe acute respiratory syndrome-associated coronavirus (SARS-CoV), Middle East respiratory syndrome-related coronavirus (MERS-CoV), SARS-CoV-2, the cause of Coronavirus disease (COVID-19). The Company, through Dominari Securities, LLC, provides wealth management services, asset management services, investment banking, and sales and trading. Its wealth management services include full-service brokerage, wealth planning, and margin lending.
